Brief: Cognition Therapeutics Reports First Quarter 2022 Financial Results And Provides Business Update
11/05/2022 12:11
May 11 (Reuters) - Cognition Therapeutics Inc CGTX.O :
* COGNITION THERAPEUTICS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q1 LOSS PER SHARE $0.17
* ESTIMATES THAT IT HAS SUFFICIENT CASH TO FUND OPERATIONS
AND
CAPITAL EXPENDITURES INTO SECOND HALF OF 2023
Source text for Eikon: ID:nGNXbRN92M
Further company coverage: CGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cognition Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Cognition rises after FDA backs late-stage trial plan for dementia drug
Brief: Cognition Therapeutics Announces Issuance Of Composition Of Matter Patent, Extending Protection For Zervimesine (CT1812) Through 2045
Brief: Cognition Therapeutics Schedules A Type C Meeting With FDA To Align On Endpoints For Phase 3 Trial Of Zervimesine (Ct1812) In DLB